Found 0 matching trials
Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis PHASE3 The RAISE-XT study is an open-label extension study to evaluate the long-te...
Show More Learn More & Join Trial
The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B) PHASE1 The purpose of this study is to investigate the safety and activity in the ...
Show More Location
Arensia Clinical Research Unit
Learn More & Join Trial
A Study of Rebif® in Subjects With Relapsing Multiple Sclerosis PHASE4 This is an open-label, multi-center, 12-week, randomized, controlled, paral...
Show More Location
Please contact the Merck KGaA Communication Center
Learn More & Join Trial
A Study of ZT002 Injection With Subjects With Overweight or Obesity PHASE2 This study will evaluate the percentage change from baseline in weight afte...
Show More Location
Handan First Hospital
Learn More & Join Trial
A Study of Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal Impairment PHASE4 This study will evaluate the pharmacokinetics (area under the curve \[AUC\]...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes PHASE3 The main purpose of this study is to evaluate the safety and efficacy of on...
Show More Location
The Second People's Hospital of Hefei
Learn More & Join Trial
Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis PHASE2 Primary Objective:
To evaluate, in comparison with placebo, the efficacy o...
Show More Location
Investigational Site Number 8400006
Learn More & Join Trial
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer PHASE3 RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamid...
Show More Status
Active Not Recruiting
Location
Regional Medical Center
Learn More & Join Trial
Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY) PHASE3 Use of PTH (1-84) a recombinant hormone in 25 µg or 50 µg doses for the tre...
Show More Location
Advance Medical Research LLC
Learn More & Join Trial
Pilot Study of CC 486 (Oral Azacitidine) Plus BSC as Maintenance After sc Azacitidine in Elderly HR-IPSS-R MDS Patients PHASE2 Treatment of higher-risk (intermediate, high and very high) Myelodysplastic...
Show More Location
AOU Careggi- University of Florence
Learn More & Join Trial